Skip to main content
Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.820
+0.170 (6.42%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Codexis Revenue

In the year 2025, Codexis had annual revenue of $70.39M with 18.61% growth. Codexis had revenue of $38.92M in the quarter ending December 31, 2025, with 81.34% growth.

Revenue (ttm)
$70.39M
Revenue Growth
+18.61%
P/S Ratio
3.64
Revenue / Employee
$482,103
Employees
146
Market Cap
256.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202570.39M11.04M18.61%
Dec 31, 202459.35M-10.80M-15.39%
Dec 31, 202370.14M-68.45M-49.39%
Dec 31, 2022138.59M33.84M32.30%
Dec 31, 2021104.75M35.70M51.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arcturus Therapeutics Holdings 82.03M
Compugen 72.76M
Coherus Oncology 42.17M
C4 Therapeutics 35.95M
Alector 21.05M
SAB Biotherapeutics 114.70K
Revenue Rankings

CDXS News

More News